Tumor-infiltrating T lymphocytes: Friends or foes?

Ping Yu, Yang Xin Fu

Research output: Contribution to journalReview article

190 Citations (Scopus)

Abstract

The prognostic significance of tumor-infiltrating lymphocytes (TILs) has been a longstanding topic of debate. In cases where TILs have improved patient outcome, T lymphocytes are recognized as the main effectors of antitumor immune responses. However, recent studies have revealed that a subset of CD4 + T cells, referred to as CD4+CD25+ regulatory T cells (Treg), may accumulate in the tumor environment and suppress tumor-specific T-cell responses, thereby hindering tumor rejection. Hence, predicting tumor behavior on the basis of an indiscriminate evaluation of tumor-infiltrating T cells may result in inconsistent prognostic accuracy. The presence of infiltrating CD4+CD25+ Treg may be detrimental to the host defense against the tumor, while the presence of effector T lymphocytes, including CD8+ T cells and nonregulatory CD4+ helper T cells may be beneficial. Enhanced recruitment of antitumor effector T lymphocytes to tumor tissue in addition to inhibition of local Treg, may therefore be an ideal target for improving cancer immunotherapy. This article reviews the antitumor functions of T-lymphocytes, with special attention given to CD4+ regulatory T-cells within the tumor environment.

Original languageEnglish (US)
Pages (from-to)231-245
Number of pages15
JournalLaboratory Investigation
Volume86
Issue number3
DOIs
StatePublished - Mar 1 2006

Fingerprint

Tumor-Infiltrating Lymphocytes
T-Lymphocytes
Neoplasms
Regulatory T-Lymphocytes
T-Lymphocyte Subsets
Helper-Inducer T-Lymphocytes
Immunotherapy

Keywords

  • CD4 T cells
  • CD4CD25 regulatory T cells
  • CD8 T cells
  • Immunotherapy
  • Tumor immunology
  • Tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Tumor-infiltrating T lymphocytes : Friends or foes? / Yu, Ping; Fu, Yang Xin.

In: Laboratory Investigation, Vol. 86, No. 3, 01.03.2006, p. 231-245.

Research output: Contribution to journalReview article

@article{8d902d5095f1434cbf471f7f0260bd21,
title = "Tumor-infiltrating T lymphocytes: Friends or foes?",
abstract = "The prognostic significance of tumor-infiltrating lymphocytes (TILs) has been a longstanding topic of debate. In cases where TILs have improved patient outcome, T lymphocytes are recognized as the main effectors of antitumor immune responses. However, recent studies have revealed that a subset of CD4 + T cells, referred to as CD4+CD25+ regulatory T cells (Treg), may accumulate in the tumor environment and suppress tumor-specific T-cell responses, thereby hindering tumor rejection. Hence, predicting tumor behavior on the basis of an indiscriminate evaluation of tumor-infiltrating T cells may result in inconsistent prognostic accuracy. The presence of infiltrating CD4+CD25+ Treg may be detrimental to the host defense against the tumor, while the presence of effector T lymphocytes, including CD8+ T cells and nonregulatory CD4+ helper T cells may be beneficial. Enhanced recruitment of antitumor effector T lymphocytes to tumor tissue in addition to inhibition of local Treg, may therefore be an ideal target for improving cancer immunotherapy. This article reviews the antitumor functions of T-lymphocytes, with special attention given to CD4+ regulatory T-cells within the tumor environment.",
keywords = "CD4 T cells, CD4CD25 regulatory T cells, CD8 T cells, Immunotherapy, Tumor immunology, Tumor-infiltrating lymphocytes",
author = "Ping Yu and Fu, {Yang Xin}",
year = "2006",
month = "3",
day = "1",
doi = "10.1038/labinvest.3700389",
language = "English (US)",
volume = "86",
pages = "231--245",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Tumor-infiltrating T lymphocytes

T2 - Friends or foes?

AU - Yu, Ping

AU - Fu, Yang Xin

PY - 2006/3/1

Y1 - 2006/3/1

N2 - The prognostic significance of tumor-infiltrating lymphocytes (TILs) has been a longstanding topic of debate. In cases where TILs have improved patient outcome, T lymphocytes are recognized as the main effectors of antitumor immune responses. However, recent studies have revealed that a subset of CD4 + T cells, referred to as CD4+CD25+ regulatory T cells (Treg), may accumulate in the tumor environment and suppress tumor-specific T-cell responses, thereby hindering tumor rejection. Hence, predicting tumor behavior on the basis of an indiscriminate evaluation of tumor-infiltrating T cells may result in inconsistent prognostic accuracy. The presence of infiltrating CD4+CD25+ Treg may be detrimental to the host defense against the tumor, while the presence of effector T lymphocytes, including CD8+ T cells and nonregulatory CD4+ helper T cells may be beneficial. Enhanced recruitment of antitumor effector T lymphocytes to tumor tissue in addition to inhibition of local Treg, may therefore be an ideal target for improving cancer immunotherapy. This article reviews the antitumor functions of T-lymphocytes, with special attention given to CD4+ regulatory T-cells within the tumor environment.

AB - The prognostic significance of tumor-infiltrating lymphocytes (TILs) has been a longstanding topic of debate. In cases where TILs have improved patient outcome, T lymphocytes are recognized as the main effectors of antitumor immune responses. However, recent studies have revealed that a subset of CD4 + T cells, referred to as CD4+CD25+ regulatory T cells (Treg), may accumulate in the tumor environment and suppress tumor-specific T-cell responses, thereby hindering tumor rejection. Hence, predicting tumor behavior on the basis of an indiscriminate evaluation of tumor-infiltrating T cells may result in inconsistent prognostic accuracy. The presence of infiltrating CD4+CD25+ Treg may be detrimental to the host defense against the tumor, while the presence of effector T lymphocytes, including CD8+ T cells and nonregulatory CD4+ helper T cells may be beneficial. Enhanced recruitment of antitumor effector T lymphocytes to tumor tissue in addition to inhibition of local Treg, may therefore be an ideal target for improving cancer immunotherapy. This article reviews the antitumor functions of T-lymphocytes, with special attention given to CD4+ regulatory T-cells within the tumor environment.

KW - CD4 T cells

KW - CD4CD25 regulatory T cells

KW - CD8 T cells

KW - Immunotherapy

KW - Tumor immunology

KW - Tumor-infiltrating lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=33244472107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33244472107&partnerID=8YFLogxK

U2 - 10.1038/labinvest.3700389

DO - 10.1038/labinvest.3700389

M3 - Review article

C2 - 16446705

AN - SCOPUS:33244472107

VL - 86

SP - 231

EP - 245

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 3

ER -